B7-H3 in glioblastoma and beyond: significance and therapeutic strategies
Cancer has emerged as the second most prevalent disease and the leading cause of death, claiming the lives of 10 million individuals each year. The predominant varieties of cancer encompass breast, lung, colon, rectal, and prostate cancers. Among the more aggressive malignancies is glioblastoma, cat...
Saved in:
| Main Authors: | Davor Babič, Ivana Jovčevska, Alja Zottel |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Frontiers Media S.A.
2024-11-01
|
| Series: | Frontiers in Immunology |
| Subjects: | |
| Online Access: | https://www.frontiersin.org/articles/10.3389/fimmu.2024.1495283/full |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
B7H3 in Gastrointestinal Tumors: Role in Immune Modulation and Cancer Progression: A Review of the Literature
by: Sylwia Mielcarska, et al.
Published: (2025-04-01) -
Immune checkpoint B7-H3 is a potential therapeutic target in prostate cancer
by: Qi Shen, et al.
Published: (2024-12-01) -
Tumor Immunotherapy Targeting B7-H3: From Mechanisms to Clinical Applications
by: Guo Y, et al.
Published: (2025-03-01) -
B7-H3 in Cancer Immunotherapy—Prospects and Challenges: A Review of the Literature
by: Sylwia Mielcarska, et al.
Published: (2025-08-01) -
From tumor immunity to precision medicine: the next step in B7-H3/CD276 research
by: Fang Haolie, et al.
Published: (2025-03-01)